Phillip Mongiovi1, Nuran Dilek2, Connie Garland2, Michael Hunter2, John T Kissel2, Elizabeth Luebbe2, Michael P McDermott2, Nicholas Johnson2, Chad Heatwole2. 1. From the Departments of Neurology (P.M., N.D., E.L., M.P.M., C.H.) and Biostatistics and Computational Biology (M.P.M.), University of Rochester, NY; Department of Medical Genetics (C.G.), Indiana University, Indianapolis; Department of Neurology (M.H., N.J.), University of Utah, Salt Lake City; and Department of Neurology (J.T.K.), The Ohio State University Wexner Medical Center, Columbus. Phillip_Mongiovi@urmc.rochester.edu. 2. From the Departments of Neurology (P.M., N.D., E.L., M.P.M., C.H.) and Biostatistics and Computational Biology (M.P.M.), University of Rochester, NY; Department of Medical Genetics (C.G.), Indiana University, Indianapolis; Department of Neurology (M.H., N.J.), University of Utah, Salt Lake City; and Department of Neurology (J.T.K.), The Ohio State University Wexner Medical Center, Columbus.
Abstract
OBJECTIVE: To determine the frequency and relative importance of symptoms experienced by adults with spinal muscular atrophy (SMA) and to identify factors that are associated with a higher burden of disease in this population. METHODS: We conducted a cross-sectional study of 359 adults with SMA using the International SMA Patient Registry. Participants provided input regarding 20 symptomatic themes and 207 symptoms that potentially affect adults with SMA. Participants were asked about the relative importance of each symptom, and analysis was conducted to determine how age, sex, SMA type, education, mobility, and employment status relate to symptom prevalence. RESULTS: Limitations with mobility or walking (98.6%) and the inability to do activities (98.6%) were the 2 themes with the highest prevalence in the study sample. Limitation with mobility or walking was the theme that was identified as having the greatest effect on the lives of adults with SMA. Employment status was associated with the prevalence of 4 of 20 themes and a reliance on an assistive device was associated with 7 of 20 themes. The prevalence of breathing difficulties, choking or swallowing difficulties, and communication difficulties differed among those with different SMA types. CONCLUSIONS: There are many symptomatic themes that affect the lives of adults with SMA. These themes vary in prevalence and relative importance in the adult SMA population.
OBJECTIVE: To determine the frequency and relative importance of symptoms experienced by adults with spinal muscular atrophy (SMA) and to identify factors that are associated with a higher burden of disease in this population. METHODS: We conducted a cross-sectional study of 359 adults with SMA using the International SMA Patient Registry. Participants provided input regarding 20 symptomatic themes and 207 symptoms that potentially affect adults with SMA. Participants were asked about the relative importance of each symptom, and analysis was conducted to determine how age, sex, SMA type, education, mobility, and employment status relate to symptom prevalence. RESULTS: Limitations with mobility or walking (98.6%) and the inability to do activities (98.6%) were the 2 themes with the highest prevalence in the study sample. Limitation with mobility or walking was the theme that was identified as having the greatest effect on the lives of adults with SMA. Employment status was associated with the prevalence of 4 of 20 themes and a reliance on an assistive device was associated with 7 of 20 themes. The prevalence of breathing difficulties, choking or swallowing difficulties, and communication difficulties differed among those with different SMA types. CONCLUSIONS: There are many symptomatic themes that affect the lives of adults with SMA. These themes vary in prevalence and relative importance in the adult SMA population.
Authors: Susan T Iannaccone; Linda S Hynan; Anne Morton; Renee Buchanan; Christine A Limbers; James W Varni Journal: Neuromuscul Disord Date: 2009-10-28 Impact factor: 4.296
Authors: Chad Heatwole; Rita Bode; Nicholas Johnson; Christine Quinn; William Martens; Michael P McDermott; Nan Rothrock; Charles Thornton; Barbara Vickrey; David Victorson; Richard Moxley Journal: Neurology Date: 2012-07-11 Impact factor: 9.910
Authors: Nicholas E Johnson; Chad R Heatwole; Nuran Dilek; Janet Sowden; Callyn A Kirk; Denise Shereff; Michael E Shy; David N Herrmann Journal: Neuromuscul Disord Date: 2014-06-27 Impact factor: 4.296
Authors: S Piepers; L H van den Berg; F Brugman; H Scheffer; M Ruiterkamp-Versteeg; B G van Engelen; C G Faber; M de Visser; W-L van der Pol; J H J Wokke Journal: J Neurol Date: 2008-06-30 Impact factor: 4.849
Authors: Chad Heatwole; Nicholas Johnson; Rita Bode; Jeanne Dekdebrun; Nuran Dilek; James E Hilbert; Elizabeth Luebbe; William Martens; Michael P McDermott; Christine Quinn; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley Journal: Neurology Date: 2015-11-18 Impact factor: 9.910
Authors: Johanna Hamel; Nicholas Johnson; Rabi Tawil; William B Martens; Nuran Dilek; Michael P McDermott; Chad Heatwole Journal: Neurology Date: 2019-08-13 Impact factor: 9.910
Authors: Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Nadine A Kasparian; Michelle A Farrar Journal: Orphanet J Rare Dis Date: 2019-04-02 Impact factor: 4.123
Authors: Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Steve Vucic; Matthew C Kiernan; Nadine A Kasparian; Michelle A Farrar Journal: Orphanet J Rare Dis Date: 2020-03-12 Impact factor: 4.123
Authors: Bart Bartels; Janke F de Groot; Laura E Habets; Camiel A Wijngaarde; Wendy Vink; Marloes Stam; Fay-Lynn Asselman; Ruben P A van Eijk; W Ludo van der Pol Journal: Orphanet J Rare Dis Date: 2020-03-23 Impact factor: 4.123